Skip to main content

Systemic Corticosteroids for Autoimmune/Inflammatory Disorders in Children: Clinical Aspects

  • Chapter
Systemic Corticosteroids for Inflammatory Disorders in Pediatrics
  • 792 Accesses

Abstract

The use of corticosteroids, still prescribed for many inflammatory diseases, is a serious decision that is to be considered within a precise framework and with a clear objective. Corticosteroids are administered via a local or general route, in short or long courses, or as a bolus. Their anti-inflammatory effect can be temporary, and they have important side effects that must be known and evaluated, as they can often be prevented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bader-Meunier B (2001) Comment prescrire les corticoïdes systémiques ? In: Dommergues JP (ed) Corticotherapie chez l’enfant. Progrès en Pédiatrie, Doin (ed), Rueil Malmaison, France pp 31–34

    Google Scholar 

  2. Cattalini M, Maduskuie V, Fawcett PT et al (2008) Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection. Clin Exp Rheumatol 26(6):1153–1160

    CAS  PubMed  Google Scholar 

  3. Olney RC (2009) Mechanisms of impaired growth: effect of steroids on bone and cartilage. Horm Res 72(Suppl 1):30–35. Epub 2009 Nov 27. Review

    Article  CAS  PubMed  Google Scholar 

  4. Huber AM, Gaboury I, Cabral DA et al; Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium (2010) Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 62(4):516–526

    Google Scholar 

  5. Bechtold S, Dalla Pozza R, Schwarz HP, Simon D (2009) Effects of growth hormone treatment in juvenile idiopathic arthritis: bone and body composition. Horm Res 72(Suppl 1):60–64. Review

    Article  CAS  PubMed  Google Scholar 

  6. Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E (2013) Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother 4(Suppl 1):S94–S98

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pascal Pillet .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pillet, P. (2015). Systemic Corticosteroids for Autoimmune/Inflammatory Disorders in Children: Clinical Aspects. In: Cimaz, R. (eds) Systemic Corticosteroids for Inflammatory Disorders in Pediatrics. Adis, Cham. https://doi.org/10.1007/978-3-319-16056-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16056-6_3

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-16055-9

  • Online ISBN: 978-3-319-16056-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics